What is OnKure Therapeutics, Inc. Class A Common Stock's Market Cap?

OnKure Therapeutics, Inc. Class A Common Stock's Market Cap is $137.7M, based on as-reported figures from SEC (XBRL) filings.

What is OnKure Therapeutics, Inc. Class A Common Stock's Enterprise Value?

OnKure Therapeutics, Inc. Class A Common Stock's Enterprise Value is -$28.8M, based on as-reported figures from SEC (XBRL) filings.

What is OnKure Therapeutics, Inc. Class A Common Stock's EV / EBITDA?

OnKure Therapeutics, Inc. Class A Common Stock's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.

What is OnKure Therapeutics, Inc. Class A Common Stock's Net Income (TTM)?

OnKure Therapeutics, Inc. Class A Common Stock's Net Income (TTM) is -$58.7M, based on as-reported figures from SEC (XBRL) filings.

What is OnKure Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM)?

OnKure Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.

What is OnKure Therapeutics, Inc. Class A Common Stock's Net Debt?

OnKure Therapeutics, Inc. Class A Common Stock's Net Debt is -$166.5M, based on as-reported figures from SEC (XBRL) filings.

OnKure Therapeutics, Inc. Class A Common Stock (OKUR) Financial Statements

OnKure Therapeutics, Inc. Class A Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00JVRSRD0

XNAS · usd

3.40▼ 0.18 (-5.03%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.58

Day's Range3.34 – 3.90

52-Week Range2.22 – 5.38

Volume114.8K

Avg Volume149.8K

Share Statistics

Shares Outstanding

Employees45

ExchangeXNAS

Listed2024-10-07

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about OnKure Therapeutics, Inc. Class A Common Stock (OKUR)

What is OnKure Therapeutics, Inc. Class A Common Stock's Market Cap?: OnKure Therapeutics, Inc. Class A Common Stock's Market Cap is $137.7M, based on as-reported figures from SEC (XBRL) filings.
What is OnKure Therapeutics, Inc. Class A Common Stock's Enterprise Value?: OnKure Therapeutics, Inc. Class A Common Stock's Enterprise Value is -$28.8M, based on as-reported figures from SEC (XBRL) filings.
What is OnKure Therapeutics, Inc. Class A Common Stock's EV / EBITDA?: OnKure Therapeutics, Inc. Class A Common Stock's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is OnKure Therapeutics, Inc. Class A Common Stock's Net Income (TTM)?: OnKure Therapeutics, Inc. Class A Common Stock's Net Income (TTM) is -$58.7M, based on as-reported figures from SEC (XBRL) filings.
What is OnKure Therapeutics, Inc. Class A Common Stock's EBITDA?: OnKure Therapeutics, Inc. Class A Common Stock's EBITDA is -$61.7M, based on as-reported figures from SEC (XBRL) filings.
What is OnKure Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM)?: OnKure Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.
What is OnKure Therapeutics, Inc. Class A Common Stock's Net Debt?: OnKure Therapeutics, Inc. Class A Common Stock's Net Debt is -$166.5M, based on as-reported figures from SEC (XBRL) filings.